Leap Therapeutics Inc (LPTX)
NASDAQ:LPTX

Leap Therapeutics (LPTX) Income Statement

852 Followers

Leap Therapeutics Income Statement

Last quarter (Q1 2024), Leap Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Leap Therapeutics's net income was $-13.82M. See Leap Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 1.50M$ 1.50M$ 0.00
Cost of Revenue
------
Gross Profit
---$ 1.51M--
Operating Expense
$ 87.05M$ 87.04M$ 56.76M$ -42.93M$ 29.81M$ 33.32M
Operating Income
$ -87.05M$ -87.04M$ -56.76M$ -41.42M$ -28.31M$ -33.32M
Net Non Operating Interest Income Expense
--$ -54.00K$ -41.00K$ 54.00K$ 290.00K
Other Income Expense
$ -88.00K$ -500.00K-$ -1.24M$ 738.00K$ 126.00K
Pretax Income
$ -88.02M$ -81.41M$ -54.45M$ -40.61M$ -27.52M$ -32.90M
Tax Provision
--$ 147.00K$ -24.00K$ -2.00K$ -3.00K
Earnings From Equity Interest Net Of Tax
---$ 9.00K--
Net Income Common Stockholders
$ -82.77M$ -81.41M$ -54.60M$ -40.59M$ -37.59M$ -33.26M
Basic EPS
$ -2.25$ -3.98$ -0.48$ -4.70$ -0.63$ -1.47
Diluted EPS
$ -2.25$ -3.98$ -0.48$ -4.70$ -0.63$ -1.47
Basic Average Shares
$ 198.06M$ 20.45M$ 113.24M$ 8.58M$ 59.33M$ 22.58M
Diluted Average Shares
$ 198.06M$ 20.45M$ 113.24M$ 8.58M$ 59.33M$ 22.58M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 87.05M$ 87.04M$ 56.76M$ -42.93M$ 29.81M$ 33.32M
Net Income From Continuing And Discontinued Operation
$ -84.79M$ -81.41M$ -54.60M$ -40.59M$ -27.51M$ -32.90M
Normalized Income
$ -38.50M$ -64.32M$ -43.01M-$ -28.25M$ -33.03M
Interest Expense
----$ 39.00K$ 23.00K
EBIT
$ -88.02M$ -81.41M$ -54.40M$ -40.57M$ -27.48M$ -32.88M
EBITDA
$ -87.59M$ -81.40M$ -53.98M$ -40.01M$ -27.44M$ -32.83M
Currency in USD

Leap Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis